Refine by
Cancer Patient Equipment Supplied In Italy
8 equipment items found
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
PCa GnRH Agonists Simulator enables simulations of clinical trials on a virtual population of prostate cancer patients being treated with a GnRH agonist ...
Manufactured by:InSilicoTrials Technologies based inStafford, VIRGINIA (USA)
A tool that performs in silico clinical trials to assess the neutropenic effects of a chemotherapeutic agent in a virtual population of cancer patients ...
Manufactured by:ICU Medical, Inc. based inSan Clemente, CALIFORNIA (USA)
With the ChemoLock needlefree CSTD, it has never been easier to keep yourself safe from exposure to hazardous drugs. Treating cancer patients takes compassion—it shouldn’t take a toll on your health. But the fact is, while chemotherapy is the backbone of medical oncology, these powerful medications—along with many others—are extremely ...
Manufactured by:Imaginalis S.r.l based inSesto Fiorentino (FI), ITALY
With its HU and GT-30 series machines, Imaginalis has reached the highest levels of flat-panel CT technology, overcoming the boundaries that often come with scanning hard ...
Manufactured by:Imaginalis S.r.l based inSesto Fiorentino (FI), ITALY
With its HU and GT-30 series machines, Imaginalis has reached the highest levels of flat-panel CT technology, overcoming the boundaries that often come with scanning hard ...
Manufactured by:Imaginalis S.r.l based inSesto Fiorentino (FI), ITALY
With its HU and GT-30 series machines, Imaginalis has reached the highest levels of flat-panel CT technology, overcoming the boundaries that often come with scanning hard ...
Manufactured by:Imaginalis S.r.l based inSesto Fiorentino (FI), ITALY
With its HU and GT-30 series machines, Imaginalis has reached the highest levels of flat-panel CT technology, overcoming the boundaries that often come with scanning hard ...
Manufactured by:Haemopharm Healthcare S.r.l. based inMilano, ITALY
The toxic effects of antineoplastic drugs used for cancer treatment, beyond the patient safety concerns, bring the occupational risks to health care workers handling hazardous drugs in the course of their duties. Multiple international studies(1) have documented, that healthcare workers who handle cytotoxic drugs have an increased risk of developing ...